Antitumor/anti-angiogenesis efficacy of epigallocatechin gallate nanoformulated with antioxidant in melanoma

Nanomedicine (Lond). 2022 Jun;17(15):1039-1053. doi: 10.2217/nnm-2021-0362. Epub 2022 Sep 14.

Abstract

Aim: Epigallocatechin gallate (EGCG) derived from green tea has poor stability; therefore, to enhance its bioavailability and anticancer efficiency, we synthesized three different nanoformulations. We hypothesized that these three nanoformulations of EGCG (nano-EGCG) would enhance EGCG's stability and improve its anticancer and antiangiogenic activity against melanoma compared with free EGCG. Methods: We prepared nano-EGCG using a copolymerization method with the UV blocker ZnO and the antioxidants lycopene and olive oil. Results: The different nano-EGCG formulation exhibited improved EGCG stability and greater suppression of melanoma growth than free EGCG. Nanoformulation preparation methods efficiently prevented the loss of EGCG activity and are a favorable approach for the treatment of melanoma. Conclusion: Nano-EGCG formulations had enhanced stability and produced greater suppression of melanoma tumor growth and angiogenesis compared with free EGCG.

Keywords: EGCG; ZnO; angiogenesis; anticancer; chick chorioallantoic membrane; epigallocatechin gallate; lycopene; melanoma; nanoemulsion; nanoformulations.

MeSH terms

  • Antioxidants / pharmacology
  • Catechin* / pharmacology
  • Catechin* / therapeutic use
  • Humans
  • Lycopene
  • Melanoma* / drug therapy
  • Olive Oil
  • Tea
  • Zinc Oxide*

Substances

  • epigallocatechin gallate
  • Antioxidants
  • Lycopene
  • Olive Oil
  • Zinc Oxide
  • Catechin
  • Tea